Loomis, Sayles & Company’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-48,953
Closed -$9.88M 989
2023
Q1
$9.88M Sell
48,953
-8,991
-16% -$1.81M 0.02% 332
2022
Q4
$12.6M Sell
57,944
-1,251
-2% -$273K 0.03% 282
2022
Q3
$11.7M Buy
59,195
+709
+1% +$140K 0.02% 288
2022
Q2
$12.5M Buy
58,486
+28,835
+97% +$6.17M 0.02% 330
2022
Q1
$8.42M Sell
29,651
-34,911
-54% -$9.91M 0.01% 381
2021
Q4
$24.3M Sell
64,562
-15,661
-20% -$5.9M 0.03% 281
2021
Q3
$33.1M Sell
80,223
-37,702
-32% -$15.6M 0.04% 234
2021
Q2
$43.6M Buy
117,925
+4,629
+4% +$1.71M 0.05% 186
2021
Q1
$32.8M Buy
113,296
+85
+0.1% +$24.6K 0.04% 214
2020
Q4
$28.3M Buy
113,211
+26,885
+31% +$6.72M 0.04% 218
2020
Q3
$19.5M Sell
86,326
-31,903
-27% -$7.22M 0.03% 237
2020
Q2
$20.6M Buy
118,229
+9,068
+8% +$1.58M 0.03% 216
2020
Q1
$13.8M Buy
109,161
+20,155
+23% +$2.54M 0.03% 242
2019
Q4
$13.6M Buy
89,006
+7,515
+9% +$1.15M 0.02% 290
2019
Q3
$10.8M Buy
+81,491
New +$10.8M 0.02% 333
2019
Q2
Sell
-174
Closed -$25K 605
2019
Q1
$25K Sell
174
-6
-3% -$862 ﹤0.01% 601
2018
Q4
$20K Sell
180
-24
-12% -$2.67K ﹤0.01% 696
2018
Q3
$27K Buy
204
+126
+162% +$16.7K ﹤0.01% 694
2018
Q2
$9K Sell
78
-184
-70% -$21.2K ﹤0.01% 800
2018
Q1
$28K Sell
262
-7
-3% -$748 ﹤0.01% 717
2017
Q4
$29K Buy
269
+43
+19% +$4.64K ﹤0.01% 699
2017
Q3
$24K Sell
226
-46
-17% -$4.89K ﹤0.01% 731
2017
Q2
$28K Buy
272
+17
+7% +$1.75K ﹤0.01% 701
2017
Q1
$23K Hold
255
﹤0.01% 751
2016
Q4
$19K Buy
+255
New +$19K ﹤0.01% 793
2016
Q2
Sell
-54
Closed -$4K 1025
2016
Q1
$4K Hold
54
﹤0.01% 949
2015
Q4
$4K Hold
54
﹤0.01% 944
2015
Q3
$3K Buy
+54
New +$3K ﹤0.01% 971